Diacutaneous Fibrolysis on Carpal Tunnel Syndrome
Effectiveness of Physiotherapy Treatment With Diacuteneous Fibrolysis in Patients With Carpal Tunnel Syndrome
1 other identifier
interventional
60
1 country
1
Brief Summary
Diacutaneous Fibrolysis is a manual method of treatment, addressed to mechanical pain of the neuromusculoskeletal system. In the clinical practice a favorable effect is observed in patients with carpal tunnel syndrome, but there is no published studies evaluating the results os this technique. The objective of this trial is to evaluate if Diacutaneous Fibrolysis is more effective in symptoms, function, grip, mechanosensitivity and neural conduction velocity compared to a placebo. For this purpose the investigators conduct a randomized controlled trial double-blind (patient and examiner). The investigators included patients diagnosed of carpal tunnel syndrome (low to moderate intensity) with a neurophysiological test. Patients included are randomized into 2 groups one receive Diacutaneous Fibrolysis and the other placebo. Both groups receive 5 treatment sessions. The variables are measured at the beginning and end of treatment. And also some variables are measured before and after each session. Patients who participated in placebo group, when the intervention finish the investigators will be given the opportunity to receive the actual technique
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2016
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 3, 2016
CompletedFirst Posted
Study publicly available on registry
March 3, 2016
CompletedStudy Start
First participant enrolled
April 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 10, 2016
CompletedNovember 21, 2017
November 1, 2017
5 months
February 3, 2016
November 19, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Intensity symptoms pre-intervention with a visual analogic scale
The investigators measure the intensity of symptoms with a visual analogic scale at baseline.
pre-intervention
Intensity symptoms post-intervention with a visual analogic scale
The investigators measure the intensity of symptoms with a visual analogic scale at the end of the intervention (2 weeks after pre-intervention) the investigators measured the intensity of symptoms (through study completion, an average 15 days)
post-intervention
Intensity symptoms after month with a visual analogic scale
The investigators measure the intensity of symptoms with a visual analogic scale after month of post-intervention.
after month
Secondary Outcomes (7)
Upper limb function pre-intervention with a validated questionnaire (DASH)
pre-intervention
Mechanosensitivity of median nerve pre-intervention with neurodynamic test
Pre-intervention
Mechanosensitivity of median nerve post-intervention with neurodynamic test
post-intervention
Neurophysiological test pre-intervention
pre-intervention
Neurophysiological test post-intervention
post-intervention
- +2 more secondary outcomes
Study Arms (2)
Intervention Goup
EXPERIMENTALActual Diacutaneous Fibrolysis
Placebo Group
SHAM COMPARATORSham Diacutaneous Fibrolysis
Interventions
Diacutaneous Fibrolysis is a non invasive physiotherapeutic technique applied by means of a set of metallic hooks ending a spatula with bevelled edges that help to treat the muscles and conjunctive tissues and trying to improve mobility between mobility between muscle planes.
Sham Diacutaneous Fibrolysis is applied at a superficial level. A pinch of skin was held with the thumb of the palpatory hand and the tip of the spatula but without effect in the muscle because no penetrate in deep tissue
Eligibility Criteria
You may qualify if:
- Diagnosed medically with neurophysiological test of carpal tunnel syndrome (low and moderate intensity)
You may not qualify if:
- Severe carpal tunnel syndrome
- Previous surgery on the hand
- hormonal factors: diabetes, thyroids pathologies, pregnant
- cervical disfunctions
- ulcerations or skins disorders
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Sandra Jiménez
Zaragoza, 50010, Spain
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sand J, Graduated
I
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal investigator
Study Record Dates
First Submitted
February 3, 2016
First Posted
March 3, 2016
Study Start
April 1, 2016
Primary Completion
September 1, 2016
Study Completion
October 10, 2016
Last Updated
November 21, 2017
Record last verified: 2017-11
Data Sharing
- IPD Sharing
- Will not share
The patient data were confidential and were assigned a number to each patient to maintain confidentiality